Thomas Filleron

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 12

Top Venues

BMC cancer

Molecular cancer research : MCR

Computational and mathematical methods in medicine

Neuro-oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Anne Laprie, Georges Noel, Leonor Chaltiel, Gilles Truc, Marie-Pierre Sunyach, Marie Charissoux, Nicolas Magne, Pierre Auberdiac, Julian Biau, Soléakhéna Ken, Fatima Tensaouti, Jonathan Khalifa, Ingrid Sidibe, Franck-Emmanuel Roux, Laure Vieillevigne, Isabelle Catalaa, Sergio Boetto, Uro-Coste Emmanuelle, Stéphane Supiot, Valérie Bernier, Thomas Filleron, Muriel Mounier, Muriel Poublanc, Pascale Olivier, Jean-Pierre Delord, Elizabeth Cohen-Jonathan-Moyal
Randomized phase III trial of metabolic imaging-guided dose escalation of radio-chemotherapy in patients with newly diagnosed glioblastoma (SPECTRO GLIO trial). Neuro-oncology (2023)
Léopoldine Lapierre, Charlotte Syrykh, Laetitia Largeaud, Bastien Cabarrou, Thomas Filleron, Lucie Oberic, Salim Kanoun, Lucie Coster, Camille Laurent, Benoît Branco, Noémie Gadaud, Christian Récher, Delphine Brechemier, Laurent Balardy, François Vergez, Loïc Ysebaert, Martin Gauthier
"Accelerated phase" chronic lymphocytic leukemia: Still an intermediate risk disease in the era of targeted therapies. Hematological oncology 40 (4) (2022)
Antoine Boden, Amélie Lusque, Sabrina Lodin, Marie Bourgouin, Valérie Mauries, Christelle Moreau, Amandine Fabre, Muriel Mounier, Muriel Poublanc, Nathalie Caunes-Hilary, Thomas Filleron
Study protocol of the TEC-ORL clinical trial: a randomized comparative phase II trial investigating the analgesic activity of capsaicin vs Laroxyl in head and neck Cancer survivors presenting with neuropathic pain sequelae. BMC cancer 22 (1) (2022)
Anne Montfort, Florie Bertrand, Julia Rochotte, Julia Gilhodes, Thomas Filleron, Jean Milhès, Carine Dufau, Caroline Imbert, Joëlle Riond, Marie Tosolini, Christopher J Clarke, Florent Dufour, Andrei A Constantinescu, Nilton De França Junior, Virginie Garcia, Michel Record, Pierre Cordelier, Pierre Brousset, Philippe Rochaix, Sandrine Silvente-Poirot, Nicole Therville, Nathalie Andrieu-Abadie, Thierry Levade, Yusuf A Hannun, Hervé Benoist, Nicolas Meyer, Olivier Micheau, Céline Colacios, Bruno Ségui
Neutral Sphingomyelinase 2 Heightens Anti-Melanoma Immune Responses and Anti-PD-1 Therapy Efficacy. Cancer immunology research 9 (5) (2021)
Monia Ezzalfani, Raphaël Porcher, Alexia Savignoni, Suzette Delaloge, Thomas Filleron, Mathieu Robain, David Pérol, null null
Addressing the issue of bias in observational studies: Using instrumental variables and a quasi-randomization trial in an ESME research project. PloS one 16 (9) (2021)
Ghassan Al Darazi, Elodie Martin, Jean-Pierre Delord, Iphigenia Korakis, Sarah Betrian, Myriam Estrabaut, Muriel Poublanc, Carlos Gomez-Roca, Thomas Filleron
Improving patient selection for immuno-oncology phase 1 trials: External validation of six prognostic scores in a French Cancer Center. International journal of cancer (2020)
Anne Montfort, Thomas Filleron, Mathieu Virazels, Carine Dufau, Jean Milhès, Cécile Pagès, Pascale Olivier, Maha Ayyoub, Muriel Mounier, Amélie Lusque, Stéphanie Brayer, Jean-Pierre Delord, Nathalie Andrieu-Abadie, Thierry Levade, Céline Colacios, Bruno Ségui, Nicolas Meyer
Combining Nivolumab and Ipilimumab with Infliximab or Certolizumab in Patients with Advanced Melanoma: First Results of a Phase Ib Clinical Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (4) (2020)
Thomas Filleron, Sophie Le Guellec, Christine Chevreau, Bastien Cabarrou, Tom Lesluyes, Sabrina Lodin, Angélique Massoubre, Muriel Mounier, Muriel Poublanc, Frédéric Chibon, Thibaud Valentin
Value of peri-operative chemotherapy in patients with CINSARC high-risk localized grade 1 or 2 soft tissue sarcoma: study protocol of the target selection phase III CHIC-STS trial. BMC cancer 20 (1) (2020)
Julia Gilhodes, Florence Dalenc, Jocelyn Gal, Christophe Zemmour, Eve Leconte, Jean-Marie Boher, Thomas Filleron
Comparison of Variable Selection Methods for Time-to-Event Data in High-Dimensional Settings. Computational and mathematical methods in medicine 2020 (2020)
Laure Malric, Sylvie Monferran, Caroline Delmas, Florent Arnauduc, Perrine Dahan, Sabrina Boyrie, Pauline Deshors, Vincent Lubrano, Dina Ferreira Da Mota, Julia Gilhodes, Thomas Filleron, Aurore Siegfried, Solène Evrard, Aline Kowalski-Chauvel, Elizabeth Cohen-Jonathan Moyal, Christine Toulas, Anthony Lemarié
Inhibiting Integrin β8 to Differentiate and Radiosensitize Glioblastoma-Initiating Cells. Molecular cancer research : MCR 17 (2) (2018)
David Garandeau, Justine Noujarède, Justine Leclerc, Caroline Imbert, Virginie Garcia, Marie-Lise Bats, Florian Rambow, Julia Gilhodes, Thomas Filleron, Nicolas Meyer, Stéphanie Brayer, Silvia Arcucci, Sophie Tartare-Deckert, Bruno Ségui, Jean-Christophe Marine, Thierry Levade, Corine Bertolotto, Nathalie Andrieu-Abadie
Targeting the Sphingosine 1-Phosphate Axis Exerts Potent Antitumor Activity in BRAFi-Resistant Melanomas. Molecular cancer therapeutics 18 (2) (2018)
Celine Lefebvre, Thomas Bachelot, Thomas Filleron, Marion Pedrero, Mario Campone, Jean-Charles Soria, Christophe Massard, Christelle Lévy, Monica Arnedos, Magali Lacroix-Triki, Julie Garrabey, Yannick Boursin, Marc Deloger, Yu Fu, Frédéric Commo, Véronique Scott, Ludovic Lacroix, Maria Vittoria Dieci, Maud Kamal, Véronique Diéras, Anthony Gonçalves, Jean-Marc Ferrerro, Gilles Romieu, Laurence Vanlemmens, Marie-Ange Mouret Reynier, Jean-Christophe Théry, Fanny Le Du, Séverine Guiu, Florence Dalenc, Gilles Clapisson, Hervé Bonnefoi, Marta Jimenez, Christophe Le Tourneau, Fabrice André
Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis. PLoS medicine 13 (12) (2016)

Thomas Filleron.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Thomas Filleron